← Leaderboards
Adrija Navarro-Traxler
Harvard Medical School
$112,595
Attributed
$112,595
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $39.3K · FY2020–22$50K$37.5K$25K$12.5K$0
'20
'21
'22
Funding mix
By agency
NIH$112,595 · 1
By mechanism
F31$112,595 · 1
Top collaborators
No co-investigators on record.
Most similar at Harvard Medical School
Same institution · by research overlap
- Marcia Haigis$12,366,449
- Suzanne L. Walker$40,048,648
- Jason Michael Crawford$9,718,195
- Jeremy Phillip Kamil$4,200,209
- Alexis Hiram Ramos$89,372
Others in their field
Other Emerging Leaders on “Affect”
- Chanza Baytop · Westat, Inc.$271,217,917
- Leonard Freedman · Leidos Biomedical Research, Inc.$62,378,387
- Jennifer Marie Suga · Kaiser Foundation Research Institute$29,218,159
- Lynn Briscoe · Leidos Biomedical Research, Inc.$27,788,199
- George Robert Painter · University Of Alabama At Birmingham$27,619,145
- Jessica Brooke Langbaum · Banner Health$22,633,312
Research focus
AffectAkt Signaling PathwayAmino AcidsAnabolismApoptosisAsparagineAutomobile DrivingBiological Adaptation To StressBreast Cancer CellBreast Cancer PatientBreast CarcinomaCancer CellCancer Cell LineCancer ControlCancer TherapyCarbohydrate MetabolismCarbohydratesCause Of DeathCell PhysiologyCellsCombined Modality TherapyDependenceEffective Therapy3q26
Grant awards (3)
Investigating the role of ALG3 in the regulation of N-glycosylation by PI3K/AKT signaling in breast and lung cancer.$34,459
F31 · FY2022 · CA · contact PI
Investigating the role of ALG3 in the regulation of N-glycosylation by PI3K/AKT signaling in breast and lung cancer.$39,326
F31 · FY2021 · CA · contact PI
Investigating the role of ALG3 in the regulation of N-glycosylation by PI3K/AKT signaling in breast and lung cancer.$38,810
F31 · FY2020 · CA · contact PI